Nyxoah: The Future Of OSA

Nyxoah's (NASDAQ: NYXH ) disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and the FDA's decision is expected in Q1 2025, which, in theory, would act as a catalyst for shares to move.As a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. Basically, anythi ...